Developer docs
API playgroundTry for free, no card

Search company profiles

Brookstreet Equity Partners

Full company profile

uuid000947m

Namestring
Brookstreet Equity Partners
Legal namestring
Brookstreet Equity Partners LLP
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Brookstreet Equity Partners LLP is a London-headquartered private equity and venture capital firm founded in 2016 by a group of shipping and principal-capital families, FCA-registered and BVCA- and UN PRI-affiliated. The firm operates a Hybrid Growth Capital strategy focused on equity-funding gap opportunities at the Series A/B stage across four thematic pillars: AI in Digital Transformation, AI in Energy Transition, AI in Longevity, and AI in Dual-Use Defence Technologies. Capital deployment targets companies with commercial risk rather than purely product risk, prioritising ROCE and DPI (cash distributions) over reported IRR in response to the post-2021 private market divergence between paper gains and realised cash returns. Revenue is generated through conventional fund-management economics — management fees, carried interest, and realised gains from exits — though specific AUM, fund vintage sizes, and revenue figures are not publicly disclosed.

The firm's operating model is built around Brookstreet Intelligence 2.0, a multi-agent, multi-council, multi-LLM autonomous AI-native architecture positioned as an embedded intelligence and execution layer across the investment lifecycle. Deal flow is sourced through a network of 450+ origination channels including Harvard, LBS, LSE, Imperial, Oxford, and Cambridge alumni and scouting infrastructure, with technical and commercial due diligence supported by the Archimedes AI research center (60+ researchers from MIT, Stanford, Imperial) and Candesic (40+ McKinsey alumni with $10B+ deal track record). Institutional co-investment relationships with WCAS ($25B AUM) and IQT provide capital backing for portfolio assets. The team of approximately 30 across leadership, investment committee, advisory board, and EIRs (notably Dr Oliver Zolman for longevity) operates from Mayfair with stated coverage across the USA, Europe, MENA, and Asia.

Brookstreet serves growth-stage founders seeking Series A/B capital, institutional co-investors participating alongside the firm, and limited partners in its fund vehicles. The portfolio spans longevity medicine (Swissmed Health), robotics and renewable energy (Perceptual Robotics), retail AI (Autonomo), behavioural AI (Behavioral Signals), maritime cybersecurity (CyberOwl, acquired by DNV), IoT/ESG platforms (Yodiwo), workforce management SaaS (Terracom, 82 countries), industrial robotics (Gizelis Robotics), and smart coatings (NanoPhos). Distribution of capital is conducted through direct equity investments and co-investments rather than via traditional product sales channels, with brand-building executed through industry events (Fortune CEO Initiative, BVCA, Delphi Economic Forum), university networks, and the FENIX female-entrepreneurship initiative.

Short descriptiontext

Brookstreet Equity Partners is a London-based private equity and venture capital firm deploying Hybrid Growth Capital at the Series A/B equity-funding gap across AI-enabled Digital Transformation, Energy Transition, Longevity, and Dual-Use Defence, operating through its proprietary Brookstreet Intelligence 2.0 multi-agent AI architecture.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
private equity investing, venture capital funding, growth equity capital, fund management services, alternative investments
Industry3 codes
1Multi-Sector / Generalist Growth Equity
CodeFSANACAOPrimaryYes
2Technology & Software Growth Equity
CodeFSANACAAPrimaryNo
3Security & Defense / GovTech Growth Equity
CodeFSANACANPrimaryNo
NAICS code4 codes
  • Portfolio Management and Investment Advice52394
  • Portfolio Management and Investment Advice523940
  • All Other Financial Investment Activities52399
  • Investment Banking and Securities Intermediation52315
SIC code3 codes
  • Investment Advice6282
  • Investors, Nec6799
  • Security Brokers, Dealers & Flotation Companies6211
Product category
Private Equity and Venture Capital Fund Management
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Private Equity and Venture Capital Management
TypeManaged Services
Description

Brookstreet generates returns through equity investments in growth-stage companies across AI-enabled enterprise, energy transition, longevity, and dual-use technologies. The firm focuses on equity-funding gap opportunities (Series A/B) with emphasis on ROCE (Return on Capital Employed) and DPI (Distributions to Paid-In capital). Revenue is generated through carried interest, management fees, and realized gains from portfolio exits.

brookstreetequity.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1Brookstreet 2.0
Description

The firm's next-generation investment approach featuring Hybrid Growth Capital strategy, AI-native operating architecture with multi-agent council, and focus on the Efficiency Frontier through diversification across Stages, Markets, Regions, and Instruments.

brookstreetequity.com
+1 more record
Core offering1 text field

Brookstreet Equity Partners is a London-based private equity and venture capital firm that deploys Hybrid Growth Capital into growth-stage companies at the Series A/B equity-funding gap. It invests in AI-enabled innovations across four thematic pillars: Digital Transformation, Energy Transition, Longevity, and Dual-Use Defence Technologies. The firm operates a proprietary multi-agent AI architecture (Brookstreet Intelligence 2.0) embedded across origination, evaluation, due diligence, and portfolio monitoring.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Brookstreet Equity Partners is a London-based private equity and venture capital firm offering a unified investment management platform built around its proprietary Brookstreet Intelligence 2.0 AI architecture. The core offering consists of the Hybrid Growth Capital strategy targeting equity-funding gaps at Series A/B stages, underpinned by the Brookstreet 2.0 Thesis focused on AI-enabled innovations across Digital Transformation, Energy Transition, Longevity, and Dual-Use Defence Technologies. The firm's AI-native operating architecture (Brookstreet Intelligence 2.0) powers the investment lifecycle from origination through due diligence to portfolio monitoring.

Product and service3 records
1Brookstreet Intelligence 2.0
CategoryInvestment Technology Platform
Description

A multi-agent, multi-council, multi-LLMs, autonomous AI-native operating architecture deployed as an embedded intelligence and execution layer across the investment management lifecycle, supporting origination, evaluation, due diligence, and portfolio monitoring for Brookstreet's PE/VC activities. Used by the firm internally to support investment decisions.

2Hybrid Growth Capital
CategoryGrowth Equity Investment Strategy
Description

A dual returns investment strategy deploying capital across the equity-funding gap (Series A/B) targeting opportunities with solid plans for eminent up-rounds and clear pathways to exit, with emphasis on ROCE and DPI rather than paper IRR. Targeted at founders and management teams of growth-stage companies seeking equity capital.

3Brookstreet 2.0 Thesis
CategoryInvestment Thesis and Strategy
Description

An investment thesis built on optimising the Efficiency Frontier through Diversification across Stages, Markets, Regions, and Instruments, targeting AI innovations in Digital Transformation, Energy Transition, Longevity, and Dual-Use Defence Technologies. Provides the strategic framework guiding Brookstreet's portfolio construction.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeOthersAnnounced on2026-04-17
Description

Executive in Residence specializing in longevity science. Known for developing the '82 Organs Framework' and working with high-profile clients including Bryan Johnson. Supports investment evaluation, due diligence, and portfolio development in longevity sector.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-11-20
Description

Flagship partnership with PRAXI Network, a unit of Foundation for Research and Technology - Hellas (FORTH), the largest research organization in Greece. Collaboration includes FENIX Initiative for female entrepreneurship, innovation pitch competitions, and joint investment support programs. PRAXI provides technical support, EIC Accelerator readiness, and access to European innovation ecosystem.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Brookstreet joined UN PRI as a signatory, joining over 5,500 investors managing $121+ trillion AUM. Demonstrates commitment to ESG integration and sustainable investment practices.

Strategic tierCoreTypeTechnology or Integration
Description

Commercial due diligence partner with team of 40+ McKinsey alumni consultants and track record of 700+ projects and deals worth over $10 billion. Provides strategic and commercial assessment for portfolio investments.

Strategic tierCoreTypeTechnology or Integration
Description

Technical due diligence partner - Leading AI research center providing access to 60+ dedicated researchers from MIT, Stanford, Imperial and other top institutions for technical assessment of AI and technology investments.

Strategic tierCoreTypeOthers
Description

Trusted administrator with $2.5 trillion AUM providing fund administration, investor services and operational infrastructure for Brookstreet's investment operations.

Strategic tierCoreTypeOthers
Description

Member of UK Private Capital (formerly BVCA), the industry body for private equity and venture capital in the UK. Brookstreet participates in PEVC structuring task forces advising UK government.

8Top Universities (Harvard, LBS, LSE, Imperial, Oxford, Cambridge)
Strategic tierCoreTypeOthers
Description

Global deal flow origination through university networks, alumni associations and direct proprietary scouting efforts across Ivy League, Oxbridge, London, and EU institutions.

brookstreetequity.com
Strategic tierCoreTypeGTM or Marketing Partner
Description

Brookstreet endorses and partners with Harvard Alumni Entrepreneurs accelerator, sponsoring first prize at HarvardAE Accelerator. EIR Regina Ryan serves as President of HarvardAE.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

London-based growth equity investor in enterprise and B2B SaaS at Series A/B. Directly comparable in stage, geography, and enterprise/AI software focus.

TypeBroad incumbent
Description

Large global growth equity investor with active tech, energy and healthcare theses. Comparable in growth-stage mandate and thematic breadth, but operates at significantly greater scale and AUM.

TypeDirect peer
Description

London-based specialist growth equity firm focused on B2B software/enterprise SaaS at Series A/B. Comparable to Brookstreet in geography, stage focus (Series A/B equity-funding gap), and digital transformation / AI thesis.

TypeDirect peer
Description

European tech-focused growth equity firm investing at Series A/B and beyond. Comparable on European base, tech/digital thesis, and growth-stage mandate.

TypeDirect peer
Description

UK growth-stage investor backing tech-enabled businesses from Series A onwards. Comparable on stage, UK base, and breadth across digital, health and energy theses.

TypeRegional player
Description

Bahrain-headquartered global PE/alternative asset manager with MENA roots and European operations. Comparable on MENA presence, multi-regional footprint, and growth/buyout hybrid mandate.

TypeDirect peer
Description

Global growth equity firm with a London presence, investing in tech, healthcare, and energy. Comparable on multi-region footprint, growth-stage mandate, and thematic breadth.

TypeBroad incumbent
Description

Global growth equity investor focused on software, AI and digital transformation. Comparable on AI/software thesis and growth-stage orientation, but at much larger AUM.

TypeBroad incumbent
Description

Global growth equity investor in energy, infrastructure and emerging markets. Comparable on energy transition and emerging-markets (MENA) theses, though more infrastructure-heavy.

TypeDirect peer
Description

London-based early/growth-stage venture firm with a software and AI-forward portfolio. Comparable on UK base, growth-stage focus, and digital transformation thesis.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment29 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Brookstreet Equity Partners

Private Equity and Venture Capital Fund Managementbrookstreetequity.com

Brookstreet Equity Partners is a London-based private equity and venture capital firm deploying Hybrid Growth Capital at the Series A/B equity-funding gap across AI-enabled Digital Transformation, Energy Transition, Longevity, and Dual-Use Defence, operating through its proprietary Brookstreet Intelligence 2.0 multi-agent AI architecture.

What Brookstreet Equity Partners does

Brookstreet Equity Partners LLP is a London-headquartered private equity and venture capital firm founded in 2016 by a group of shipping and principal-capital families, FCA-registered and BVCA- and UN PRI-affiliated. The firm operates a Hybrid Growth Capital strategy focused on equity-funding gap opportunities at the Series A/B stage across four thematic pillars: AI in Digital Transformation, AI in Energy Transition, AI in Longevity, and AI in Dual-Use Defence Technologies. Capital deployment targets companies with commercial risk rather than purely product risk, prioritising ROCE and DPI (cash distributions) over reported IRR in response to the post-2021 private market divergence between paper gains and realised cash returns. Revenue is generated through conventional fund-management economics — management fees, carried interest, and realised gains from exits — though specific AUM, fund vintage sizes, and revenue figures are not publicly disclosed.

The firm's operating model is built around Brookstreet Intelligence 2.0, a multi-agent, multi-council, multi-LLM autonomous AI-native architecture positioned as an embedded intelligence and execution layer across the investment lifecycle. Deal flow is sourced through a network of 450+ origination channels including Harvard, LBS, LSE, Imperial, Oxford, and Cambridge alumni and scouting infrastructure, with technical and commercial due diligence supported by the Archimedes AI research center (60+ researchers from MIT, Stanford, Imperial) and Candesic (40+ McKinsey alumni with $10B+ deal track record). Institutional co-investment relationships with WCAS ($25B AUM) and IQT provide capital backing for portfolio assets. The team of approximately 30 across leadership, investment committee, advisory board, and EIRs (notably Dr Oliver Zolman for longevity) operates from Mayfair with stated coverage across the USA, Europe, MENA, and Asia.

Brookstreet serves growth-stage founders seeking Series A/B capital, institutional co-investors participating alongside the firm, and limited partners in its fund vehicles. The portfolio spans longevity medicine (Swissmed Health), robotics and renewable energy (Perceptual Robotics), retail AI (Autonomo), behavioural AI (Behavioral Signals), maritime cybersecurity (CyberOwl, acquired by DNV), IoT/ESG platforms (Yodiwo), workforce management SaaS (Terracom, 82 countries), industrial robotics (Gizelis Robotics), and smart coatings (NanoPhos). Distribution of capital is conducted through direct equity investments and co-investments rather than via traditional product sales channels, with brand-building executed through industry events (Fortune CEO Initiative, BVCA, Delphi Economic Forum), university networks, and the FENIX female-entrepreneurship initiative.

Brookstreet Equity Partners firmographics

Firmographics
Name
Brookstreet Equity Partners
Legal name
Brookstreet Equity Partners LLP
Website
https://brookstreetequity.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Brookstreet Equity Partners is a London-based private equity and venture capital firm deploying Hybrid Growth Capital at the Series A/B equity-funding gap across AI-enabled Digital Transformation, Energy Transition, Longevity, and Dual-Use Defence, operating through its proprietary Brookstreet Intelligence 2.0 multi-agent AI architecture.
Ownership category
akta.pro rank

Brookstreet Equity Partners industry classification

Industry
Product category
Private Equity and Venture Capital Fund Management
NAICS
Portfolio Management and Investment Advice (52394), Portfolio Management and Investment Advice (523940), All Other Financial Investment Activities (52399), Investment Banking and Securities Intermediation (52315)
SIC
Investment Advice (6282), Investors, Nec (6799), Security Brokers, Dealers & Flotation Companies (6211)
akta.pro primary industry
Multi-Sector / Generalist Growth Equity (FSANACAO)
akta.pro secondary industries
Technology & Software Growth Equity (FSANACAA), Security & Defense / GovTech Growth Equity (FSANACAN)

Keywords

  • Private equity investing
  • Venture capital funding
  • Growth equity capital
  • Fund management services
  • Alternative investments

Where Brookstreet Equity Partners is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Brookstreet Equity Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Private Equity and Venture Capital Management: Brookstreet generates returns through equity investments in growth-stage companies across AI-enabled enterprise, energy transition, longevity, and dual-use technologies. The firm focuses on equity-funding gap opportunities (Series A/B) with emphasis on ROCE (Return on Capital Employed) and DPI (Distributions to Paid-In capital). Revenue is generated through carried interest, management fees, and realized gains from portfolio exits.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Brookstreet Equity Partners product offering

Product offering

Core offering

Brookstreet Equity Partners is a London-based private equity and venture capital firm that deploys Hybrid Growth Capital into growth-stage companies at the Series A/B equity-funding gap. It invests in AI-enabled innovations across four thematic pillars: Digital Transformation, Energy Transition, Longevity, and Dual-Use Defence Technologies. The firm operates a proprietary multi-agent AI architecture (Brookstreet Intelligence 2.0) embedded across origination, evaluation, due diligence, and portfolio monitoring.

Product overview

Brookstreet Equity Partners is a London-based private equity and venture capital firm offering a unified investment management platform built around its proprietary Brookstreet Intelligence 2.0 AI architecture. The core offering consists of the Hybrid Growth Capital strategy targeting equity-funding gaps at Series A/B stages, underpinned by the Brookstreet 2.0 Thesis focused on AI-enabled innovations across Digital Transformation, Energy Transition, Longevity, and Dual-Use Defence Technologies. The firm's AI-native operating architecture (Brookstreet Intelligence 2.0) powers the investment lifecycle from origination through due diligence to portfolio monitoring.

Differentiator

Problem solved

Functional benefit

Brands

  • Brookstreet 2.0: The firm's next-generation investment approach featuring Hybrid Growth Capital strategy, AI-native operating architecture with multi-agent council, and focus on the Efficiency Frontier through diversification across Stages, Markets, Regions, and Instruments.
  • Brookstreet Intelligence 2.0

Products and services

  • Brookstreet Intelligence 2.0 A multi-agent, multi-council, multi-LLMs, autonomous AI-native operating architecture deployed as an embedded intelligence and execution layer across the investment management lifecycle, supporting origination, evaluation, due diligence, and portfolio monitoring for Brookstreet's PE/VC activities. Used by the firm internally to support investment decisions.
  • Hybrid Growth Capital A dual returns investment strategy deploying capital across the equity-funding gap (Series A/B) targeting opportunities with solid plans for eminent up-rounds and clear pathways to exit, with emphasis on ROCE and DPI rather than paper IRR. Targeted at founders and management teams of growth-stage companies seeking equity capital.
  • Brookstreet 2.0 Thesis An investment thesis built on optimising the Efficiency Frontier through Diversification across Stages, Markets, Regions, and Instruments, targeting AI innovations in Digital Transformation, Energy Transition, Longevity, and Dual-Use Defence Technologies. Provides the strategic framework guiding Brookstreet's portfolio construction.

Companies that use Brookstreet Equity Partners

Customer profile

Named customers9 records

Segments4 records

Ideal customer profiles2 records

Brookstreet Equity Partners technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature1 record

Brookstreet Equity Partners partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and flagship.

  • Dr Oliver ZolmancoreOthers · 17 April 2026Executive in Residence specializing in longevity science. Known for developing the '82 Organs Framework' and working with high-profile clients including Bryan Johnson. Supports investment evaluation, due diligence, and portfolio development in longevity sector.
  • PRAXI Network (FORTH)flagshipStrategic or Co-development Partner · 20 November 2024Flagship partnership with PRAXI Network, a unit of Foundation for Research and Technology - Hellas (FORTH), the largest research organization in Greece. Collaboration includes FENIX Initiative for female entrepreneurship, innovation pitch competitions, and joint investment support programs. PRAXI provides technical support, EIC Accelerator readiness, and access to European innovation ecosystem.
  • United Nations PRI (Principles for Responsible Investment)coreStrategic or Co-development Partner · 1 January 2024Brookstreet joined UN PRI as a signatory, joining over 5,500 investors managing $121+ trillion AUM. Demonstrates commitment to ESG integration and sustainable investment practices.
  • CandesiccoreTechnology or IntegrationCommercial due diligence partner with team of 40+ McKinsey alumni consultants and track record of 700+ projects and deals worth over $10 billion. Provides strategic and commercial assessment for portfolio investments.
  • Archimedes AI CentercoreTechnology or IntegrationTechnical due diligence partner - Leading AI research center providing access to 60+ dedicated researchers from MIT, Stanford, Imperial and other top institutions for technical assessment of AI and technology investments.
  • Alter DomuscoreOthersTrusted administrator with $2.5 trillion AUM providing fund administration, investor services and operational infrastructure for Brookstreet's investment operations.
  • BVCA (British Private Equity & Venture Capital Association)coreOthersMember of UK Private Capital (formerly BVCA), the industry body for private equity and venture capital in the UK. Brookstreet participates in PEVC structuring task forces advising UK government.
  • Top Universities (Harvard, LBS, LSE, Imperial, Oxford, Cambridge)coreOthersGlobal deal flow origination through university networks, alumni associations and direct proprietary scouting efforts across Ivy League, Oxbridge, London, and EU institutions.
  • Harvard Alumni Entrepreneurs (HAE)coreGTM or Marketing PartnerBrookstreet endorses and partners with Harvard Alumni Entrepreneurs accelerator, sponsoring first prize at HarvardAE Accelerator. EIR Regina Ryan serves as President of HarvardAE.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Brookstreet Equity Partners competitors and assessment

Company assessment

Direct peers

  • Notion Capital: London-based growth equity investor in enterprise and B2B SaaS at Series A/B. Directly comparable in stage, geography, and enterprise/AI software focus.
  • Dawn Capital: London-based specialist growth equity firm focused on B2B software/enterprise SaaS at Series A/B. Comparable to Brookstreet in geography, stage focus (Series A/B equity-funding gap), and digital transformation / AI thesis.
  • Atomico: European tech-focused growth equity firm investing at Series A/B and beyond. Comparable on European base, tech/digital thesis, and growth-stage mandate.
  • Octopus Ventures: UK growth-stage investor backing tech-enabled businesses from Series A onwards. Comparable on stage, UK base, and breadth across digital, health and energy theses.
  • Eight Roads Ventures: Global growth equity firm with a London presence, investing in tech, healthcare, and energy. Comparable on multi-region footprint, growth-stage mandate, and thematic breadth.
  • Balderton Capital: London-based early/growth-stage venture firm with a software and AI-forward portfolio. Comparable on UK base, growth-stage focus, and digital transformation thesis.

Broad incumbents

  • General Atlantic: Large global growth equity investor with active tech, energy and healthcare theses. Comparable in growth-stage mandate and thematic breadth, but operates at significantly greater scale and AUM.
  • Insight Partners: Global growth equity investor focused on software, AI and digital transformation. Comparable on AI/software thesis and growth-stage orientation, but at much larger AUM.
  • Actis: Global growth equity investor in energy, infrastructure and emerging markets. Comparable on energy transition and emerging-markets (MENA) theses, though more infrastructure-heavy.

Regional players

  • Investcorp: Bahrain-headquartered global PE/alternative asset manager with MENA roots and European operations. Comparable on MENA presence, multi-regional footprint, and growth/buyout hybrid mandate.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Brookstreet Equity Partners social profiles

Digital presence

Brookstreet Equity Partners compliance and trust

Trust signal

Compliance3 records

Brookstreet Equity Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Brookstreet Equity Partners leadership team

Management profile

Number of profiles

Profiles9 records

Brookstreet Equity Partners funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Brookstreet Equity Partners M&A and investment

M&A and investment

M&A

Investments29 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Brookstreet Equity Partners

What does Brookstreet Equity Partners do?

Brookstreet Equity Partners is a London-based private equity and venture capital firm that deploys Hybrid Growth Capital into growth-stage companies at the Series A/B equity-funding gap. It invests in AI-enabled innovations across four thematic pillars: Digital Transformation, Energy Transition, Longevity, and Dual-Use Defence Technologies. The firm operates a proprietary multi-agent AI architecture (Brookstreet Intelligence 2.0) embedded across origination, evaluation, due diligence, and portfolio monitoring.

Is Brookstreet Equity Partners a public or private company?

Brookstreet Equity Partners is a private company. It is classified as family owned and is currently operating.

When was Brookstreet Equity Partners founded?

Brookstreet Equity Partners was founded in 2016. It employs 11 to 50 people.

Where is Brookstreet Equity Partners based?

Brookstreet Equity Partners is headquartered in London, United Kingdom, in the Europe region.

How does Brookstreet Equity Partners make money?

One revenue line is on record: private Equity and Venture Capital Management.

Who are Brookstreet Equity Partners's main competitors?

Direct peers on record are Notion Capital, Dawn Capital, Atomico, Octopus Ventures, Eight Roads Ventures and Balderton Capital. Broad incumbents are General Atlantic, Insight Partners and Actis. Investcorp is listed as a regional player.

Does Brookstreet Equity Partners have an API?

No public API is recorded for Brookstreet Equity Partners.

What industry is Brookstreet Equity Partners in?

Brookstreet Equity Partners's product category is Private Equity and Venture Capital Fund Management. Its primary akta.pro industry code is FSANACAO, Multi-Sector / Generalist Growth Equity, with a secondary code of FSANACAA, Technology & Software Growth Equity. Its NAICS code is 52394 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comDr Oliver Zolman Collaborates with Brookstreet Equity Partners as Executive in ResidenceBrookstreet Equity Partners, a London-based investment manager, announced that Dr Oliver Zolman has joined the firm as Executive in Residence to strengthen its capabilities in longevity science and next-generation healthcare. Dr Zolman, a longevity medicine specialist known for developing the '82 Organs Framework' and working with high-profile clients including Bryan Johnson, will support the firm's investment evaluation, due diligence, and portfolio development in the longevity sector. Brookstreet operates globally across AI-enabled enterprise, energy transition, longevity, and dual-use technologies.PR NewswireAutonomo accélère sa croissance - La société allemande Autonomo, leader dans le domaine de la vision par ordinateur et de l'intelligence artificielle, accueille le détaillant Meyer, qui fait partie duAutonomo GmbH, a German computer vision and AI technology provider for retail, has announced new investment from Brookstreet Equity Partners alongside its first client Meyer, which is part of EDEKA Group, Germany's largest food retailer. The investment will fund the opening of multiple autonomous stores in northern Germany equipped with AI, computer vision, and machine learning technologies to address labor shortages and meet consumer demand for convenient shopping. The first autonomous store will offer products including fresh produce, dairy, meats, wines, beers, and bakery items, allowing customers to access the store and make purchases using credit/debit cards or smartphones without human staff.PR NewswireAutonomo beschleunigt sein Wachstum - Das führende deutsche Unternehmen für Computer Vision und KI Autonomo begrüßt Brookstreet Equity Partners aus London als Kerninvestor und Einzelhändler Meyer, TeiAutonomo GmbH, a German computer vision and AI company for retail, announced a new investment from London-based Brookstreet Equity Partners alongside its first customer partnership with Meyer, part of the EDEKA Group. The collaboration will open several autonomous stores in northern Germany equipped with AI, computer vision, and machine learning technology to address labor shortages and meet customer demand for convenient shopping. Autonomo was founded in 2021 by Patrick Müller-Sarmiento and James Sutherland.BrookstreetequityBehavioral Signals — Brookstreet Equity Partners LLPBrookstreet Equity Partners LLP announced an investment in Behavioral Signal Technologies, an AI company specializing in emotion recognition and behavioral signal processing based in Los Angeles. The deal was advised by Polsinelli, Lowenstein Sandler, Papapolitis & Papapolitis, Candesic, and Alter Domus, with Barclays serving as the banker.ThenationalheraldInvestment in Brookstreet Equity Partners Boosts GreeceBrookstreet Equity Partners LLP, a London-based FCA-registered fund manager, has partnered with Austrian investment manager QINO GS through a capital increase to expand its venture capital, private equity, and ESG investment platform globally. The investment accelerates Brookstreet's growth plans and enhances its intellectual capital and infrastructure base, while providing QINO access to private investment strategies and energy infrastructure opportunities. Both firms are committed investors in Greece and Cyprus, with the partnership providing immediate access to UK and European markets with scale-up ability to the United States, Middle East, and Asia.PR NewswireQINO GS Invests In Brookstreet Equity Partners LLPQINO GS, the investment vehicle of Austrian Investment Manager Gottfried Springer, has invested in Brookstreet Equity Partners LLP to build a global private equity and venture capital platform. The capital increase accelerates Brookstreet's growth plans and enhances its intellectual capital and infrastructure base while providing QINO access to private investment strategies. Both firms are focused on ESG investing and will leverage combined expertise across UK, European, US, Middle East, and Asian markets.PR NewswireLondon-based Brookstreet Equity and Its Greek Tech Investments Are Fighting CoronavirusBrookstreet Equity Partners, a London-based private equity investor, announced that three of its Greek technology portfolio companies are contributing to the COVID-19 response. Terracom is offering its QR-Patrol and MyLoneWorkers workforce management software free of charge to healthcare institutions worldwide through the end of 2020, while Gizelis Robotics is developing ultraviolet disinfection robots for hospitals and factories, and NanoPhos is repurposing part of its production to manufacture nano-enhanced health sanitisers. The Managing Partner stated the companies are working to expand their community and customer support initiatives.